H.C. Wainwright Reiterates Buy Rating on Gain Therapeutics (GANX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| (NASDAQ: GANX) | Delayed: 1.57 -0.07 (4.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.64 | 52 Week High | $ | |||
| Open | $1.65 | 52 Week Low | $ | |||
| Day High | $1.65 | P/E | N/A | |||
| Day Low | $1.57 | EPS | $ | |||
| Volume | 319,595 | |||||
